Publicaciones en colaboración con investigadores/as de Guy's Hospital (10)

2023

  1. AIPSS-MF machine learning prognostic score validation in a cohort of myelofibrosis patients treated with ruxolitinib

    Cancer Reports, Vol. 6, Núm. 10

  2. CNL and aCML should be considered as a single entity based on molecular profiles and outcomes

    Blood Advances, Vol. 7, Núm. 9, pp. 1672-1681

2022

  1. Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT

    Bone Marrow Transplantation, Vol. 57, Núm. 3, pp. 416-422

  2. Correction: Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT (Bone Marrow Transplantation, (2022), 57, 3, (416-422), 10.1038/s41409-021-01553-x)

    Bone Marrow Transplantation

2020

  1. Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: A case-control study

    Blood, Vol. 135, Núm. 5, pp. 381-386

  2. Reply to: Second primary malignancies in myeloproliferative neoplasms and the role of aspirin

    Leukemia

  3. Second cancers in MPN: Survival analysis from an international study

    American Journal of Hematology, Vol. 95, Núm. 3, pp. 295-301

2019

  1. Second cancer in Philadelphia negative myeloproliferative neoplasms (MPN-K). A nested case-control study

    Leukemia, Vol. 33, Núm. 8, pp. 1996-2005

2014

  1. Peripheral blood hematopoietic stem cells for transplantation of hematological diseases from related, haploidentical donors after reduced-intensity conditioning

    Biology of Blood and Marrow Transplantation, Vol. 20, Núm. 6, pp. 890-895

2002

  1. Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia

    Blood, Vol. 100, Núm. 12, pp. 3877-3886